Dr. Richmon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
243 Charles Street
Boston, MA 02114Phone+1 617-573-3669Fax+1 617-573-4131
Summary
- Dr. Jeremy Richmon is a fellowship-trained head and neck surgeon who specializes in head and neck cancer and microvascular reconstruction. A 2001 graduate of the University of Rochester School of Medicine, Dr. Richmon completed his residency in otolaryngology at the University of California, San Diego, in 2007, and a clinical fellowship in head/neck oncology, microvascular reconstruction, and skull base surgery at Mass. Eye and Ear/Harvard Medical School in 2008. He joined the faculty at Johns Hopkins in 2008 and served as the Director of the Head and Neck Surgery Robotic Program until joining the Mass. Eye and Ear Head and Neck Division as a Clinical Associate and the Harvard Medical School faculty in 2016.
Dr. Richmon has become a pioneer in minimally-invasive robotic techniques in the head and neck. He was the first surgeon to perform transoral robotic surgery at Johns Hopkins in 2009 and developed a robust head and neck robotic surgery program of international renown. He has collaborated with engineers and computer scientists to bring the next generation of robotics into the clinical realm and began the robotic thyroid surgery program at Johns Hopkins. Dr. Richmon was also the first surgeon in the United States to perform transoral robotic thyroidectomy, a technique he helped develop.
Throughout his career, Dr. Richmon has actively participated in resident and fellow education and has been responsible for the development of residency training curriculums specific to head and neck robotic surgery. He sits on the editorial advisory board for Gland Surgery as well as various national head and neck oncology and reconstructive committees. He has been an invited speaker at national and international meetings and has published more than 85 peer-reviewed papers.
Dr. Richmon’s clinical interests include head and neck cancer, skull base surgery, robotic surgery, and microvascular reconstruction of the head and neck.
Clinical Expertise
- Head and neck oncology and microvascular reconstruction, Head and neck microvascular reconstruction, Facial plastic and reconstructive surgery, Rhinology and sinus disease, Head and neck oncology, Plastic and reconstructive microsurgery, Clinical research, Healthcare outcomes research, Flaps, Post-operative complications, Immunohistochemistry, Minimally Invasive Surgical Procedures, Analysis of Variance, Laryngology, Swallowing disorders, Neoplasm staging, Laryngectomy, Head and neck neoplasms, Thyroidectomy, Thyroid disease, Squamous cell carcinoma of the tongue, Spasmodic dysphonia, Head and neck surgery, Plastic surgery, Thyroid disorders
Education & Training
- Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolFellowship, Head & Neck Surgical Oncology/Microvascular Reconstruction, 2007 - 2008
- University of California (San Diego) Medical CenterResidency, Otolaryngology - Head and Neck Surgery, 2002 - 2007
- University of California (San Diego) Medical CenterInternship, Transitional Year, 2001 - 2002
- University of Rochester School of Medicine and DentistryClass of 2001
- Amherst CollegeB.A., Neuroscience, Magna Cum Laude, 1992 - 1996
Certifications & Licensure
- CA State Medical License 2002 - Present
- MA State Medical License 2016 - 2025
- MD State Medical License 2008 - 2017
- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
- ‘Excellence in Teaching’ Johns Hopkins George T. Nager, MD Faculty, 2010
- Join now to see all
Clinical Trials
- Treatment De-Intensification for Squamous Cell Carcinoma of the Oropharynx Start of enrollment: 2010 Mar 01
- Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer Start of enrollment: 2014 Jan 22
- ALM-488 for Intra-Operative Visualization of Nerves in Head and Neck Surgery Start of enrollment: 2022 Apr 29
Roles: Contact
Publications & Presentations
PubMed
- 586 citationsEvidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinomaSofia Lyford-Pike, Shiwen Peng, Geoffrey D. Young, Janis M. Taube, William H. Westra
Cancer Research. 2013-03-15 - 108 citationsTransoral thyroidectomy and parathyroidectomy – A North American series of robotic and endoscopic transoral approaches to the central neckJonathon O. Russell, James H. Clark, Salem I. Noureldine, Angkoon Anuwong, Mai G. Al Khadem
Oral Oncology. 2017-08-01 - 127 citationsThe "new" head and neck cancer patient-young, nonsmoker, nondrinker, and HPV positive: evaluation.Daniel G. Deschler, Jeremy D. Richmon, Samir S. Khariwala, Robert L. Ferris, Marilene B. Wang
Otolaryngology--Head and Neck Surgery. 2014-06-12
Journal Articles
- Transoral Robotic Surgery (TORS) of the parapharyngeal space: A case series and systematic reviewChan JY, Tsang RK, Eisele DW, Richmon JD, Head Neck, 11/29/2013
- Role of Robotic Surgery for an Unknown Primary Head and Neck Squamous Cell CarcinomaPatel SA, Magnuson JS, Holsinger FC, Karni RJ, Richmon JD, Gross ND, Bhrany AD, Ferrell JK, Ford SE, Kennedy A, Mendez E, JAMA – Otolaryngol Head Neck Surg, 11/1/2013
- Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV associated head and neck squamous cell carcinomaLyford-Pike S, Peng S, Young GD, Taube JM, Westra WH, Akpeng B, Bruno TC, Richmon JD, Wang H, Bishop JA, Chen L, Drake CG, Topalian SL, Pardoll DM, Pai SI, Cancer Res, 1/3/2013
- Join now to see all
Authored Content
- Salvage of Recurrence After Surgery and Adjuvant Therapy: A Systematic Review☆☆☆February 2018
Press Mentions
- New Blood Test Provides More Accurate, Faster Diagnosis of HPV-Associated Head and Neck CancerDecember 2nd, 2021
- Salvage Arterial Anastomosis Using a Microvascular Coupler in Head and Neck Free Flap ReconstructionOctober 18th, 2016
Research History
- Head and Neck ResearchResearch Summary Dr. Richmon conducts research on microvascular reconstructive techniques of head and neck defects, robotic surgery, and minimally invasive approaches to head and neck cancer. Select Publications Prognostic implication of persistent human papillomavirus type 16 DNA detection in2008 - 2016
Professional Memberships
- Member
- Member
- American Head and Neck SocietyMember
- Triological SocietyFellow
Other Languages
- Spanish
External Links
- Mass Eye and Ear Physicianshttp://www.masseyeandear.org/find-a-physician/r/richmon-jeremy
- Atrius Physicianshttps://www.atriushealth.org/clinicians/jeremy-richmon-12042
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: